Western Coal Corp. (TSX: WTN), $3.43, +0.28, 8.89%, is making considerable gains today trading near the day’s high of 3.47 touching down on a low of 3.26.  Western Coal released its operating results for the three and nine month period ending December 31, 2009.  Some key points included consolidated revenues of $118.7 million were 10% higher than fiscal second quarter 2010, attributable to 175,000 tonnes of coal sold at previous coal year prices.  Western Coal also reports that they commenced operations on a permit for Maple Coal surface mine which increases reserves of marketable tons to over 10 million short tons, which is a 67% increase in the Maple surface reserves.  Western is a producer of high quality metallurgical and thermal coal from mines located in northeast British Columbia and West Virginia.

Arco Resources Corp. (TSXV: ARR), $0.06, +0.015, 33.33%, is trading in a tight spread between 0.045 and 0.07, coming close to reaching its 52 week-high of 0.075.  The company holds a 100% interest in six mineral claim blocks in Oaxaca, Mexico.  Arco reported on its underground sampling program from its 386 hectare Taviche property.  The results showed a 230 metre long shoot of the vein with silver-gold values averaging 173 g/t silver (Ag) and 1.5 g/t gold (Au).  Other samplings identified a similar 220 metre long shoot averaging 161 g/t Ag and 2.18 g/t Au.  The Tavish vein is a silver-gold-bearing quartz vein.

Rexahn Pharmaceuticals Inc. (AMEX: RNN), $0.76, +0.07, 10.14%, is a clinical stage pharmaceutical company focused on treatments of cancer, CNS disorders, sexual dysfunction and other medical needs.  The company has three drug candidates in Phase II clinical trials, Archexin™, Serdaxin™ and Zoraxel™.  RNN has been trading today between the 0.68 and 0.825 range on gains of over 10%.  Rexahn is presenting today at the 12th Annual BIO CEO & Investor Conference.  Rexhan’s Chairman and CEO, Dr. Chang H. Ahn, will speak about a business overview and provide updates on Rexahn’s recent clinical and financing milestones.

Cord Blood America Inc. (OTCBB: CBAI), $0.01, +0.001, 11.11%, is trading the day away in the range of 0.009 and 0.011, with the 52 week-high sitting at 0.02.  Cord Blood announced yesterday that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc.  BioCells is the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD) and 12 locations throughout that country.  Cord Blood America facilitates umbilical cord blood stem cell preservation for expectant parents and their children.

Cell Therapeutics Inc. (NASDAQ: CTIC), $0.78, +0.14, 21.88%, focuses on the development, acquisition and commercialization of drugs for the treatment of cancer.  On February 11, 2010, the Cell Therapeutic’s team will host a conference call to review the Company’s 2009 fourth quarter and year-end achievements and financial results.  Cell Therapeutics is trading between 0.74 and 0.80, with its 52 week-high sitting at 2.23.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Related posts:

1. Investment Opinion On CTIC, WTN, HEB, PNXE, MJS MJS up, 27.27%, closed on the day’s high today surpassing...
2. Investment Opinion On LEN, CCJ, BZH, PAL, CBAI CCJ up 10.20% on news it will sell the La...
3. Investment Opinion LDK, CCJ, EZ, SBUX, CBAI Ldk Solar Co Ltd. (NYSE: LDK), $8.67, +0.67, 8.38%, is...
4. Investment Opinion On RAD, WTN, GETA, ANX, SNSS Genta Inc. (OTCBB: GETA) up 66.27%, the company currently has...
5. Investment Opinion On CCJ, SEED, KBX, ISCR, AQA Aquila Resources up 35.42% on high grade assay results. Aquila...

Related posts brought to you by Yet Another Related Posts Plugin.